Inventor · disambiguated record
Eli M. Wallace
Also filed as: WALLACE ELI · WALLACE ELI M
92 granted patents·31 pending applications·1,029 citations·filing 1999–2025
99Inventor score
Files withARRAY BIOPHARMA INC56PELOTON THERAPEUTICS INC15BLAKE JAMES F7MARLOW ALLISON L7WALLACE ELI M6
Top patents by PatentIndex Score
123 records- 0197US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0296US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 0396US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 0496US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 0596US7425637B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2005·Granted Sep 16, 2008·27 cites·1 claims
- 0696US6197798B1Amino-benzocycloalkane derivativesNOVARTIS AG·Filed 1999·Granted Mar 6, 2001·108 cites·16 claims
- 0795US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0895US7777032B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Aug 17, 2010·11 cites·2 claims
- 0995US7585975B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Sep 8, 2009·11 cites·16 claims
- 1094US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 1194US7777050B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 17, 2010·13 cites·9 claims
- 1293USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 1393US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 1493US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 1593US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 1693US8324221B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 4, 2012·54 cites·60 claims
- 1793US8178131B2Pyrrolopyridines as kinase inhibitorsLE HUEROU YVAN·Filed 2009·Granted May 15, 2012·24 cites·36 claims
- 1893US7235537B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Jun 26, 2007·53 cites·10 claims
- 1992US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 2092US7893065B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Feb 22, 2011·14 cites·20 claims
- 2192US7271178B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 18, 2007·18 cites·17 claims
- 2291US8211921B2Heterocyclic inhibitors of MEK and methods of useBLAKE JAMES F·Filed 2009·Granted Jul 3, 2012·12 cites·5 claims
- 2391US7538120B2Method of treating inflammatory diseasesARRAY BIOPHARMA INC·Filed 2005·Granted May 26, 2009·11 cites·9 claims
- 2490US9676791B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2012·Granted Jun 13, 2017·5 cites·9 claims
- 2590US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 2690US8981085B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Mar 17, 2015·10 cites·20 claims
- 2790US8372842B2Pyrazolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Feb 12, 2013·15 cites·53 claims
- 2889US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 2989US9969727B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted May 15, 2018·6 cites·23 claims
- 3089US7795282B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 14, 2010·9 cites·2 claims
- 3189US7598383B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Oct 6, 2009·19 cites·1 claims
- 3289US7501427B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Mar 10, 2009·14 cites·37 claims
- 3389US7144907B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2003·Granted Dec 5, 2006·33 cites·34 claims
- 3488US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 3588US7956073B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Jun 7, 2011·8 cites·11 claims
- 3688US7576114B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 18, 2009·5 cites·1 claims
- 3787US10335388B2Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Jul 2, 2019·4 cites·21 claims
- 3887US10278942B2Compositions for use in treating pulmonary arterial hypertensionPELOTON THERAPEUTICS INC·Filed 2016·Granted May 7, 2019·7 cites·16 claims
- 3987US9365568B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jun 14, 2016·4 cites·12 claims
- 4087US9221841B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Dec 29, 2015·5 cites·19 claims
- 4187US8431574B2Heterocyclic inhibitors of MEK and methods of use thereofBLAKE JAMES F·Filed 2009·Granted Apr 30, 2013·6 cites·6 claims
- 4287US8329709B25H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 11, 2012·10 cites·33 claims
- 4387US8236825B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2011·Granted Aug 7, 2012·7 cites·24 claims
- 4487US7511058B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Mar 31, 2009·8 cites·18 claims
- 4586US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 4686US8758830B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jun 24, 2014·6 cites·27 claims
- 4786US8513293B2Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammalWALLACE ELI M·Filed 2012·Granted Aug 20, 2013·5 cites·4 claims
- 4886US8003805B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2010·Granted Aug 23, 2011·5 cites·7 claims
- 4986US7973170B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2010·Granted Jul 5, 2011·5 cites·7 claims
- 5086US7230099B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Jun 12, 2007·30 cites·15 claims
Showing the top 50 of 123 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eli M. Wallace files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →